Skip to main content
All lobbying clients

THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying client · Maryland · filed 2025 to 2026

$1,190,000 Reported spend
20 Filings counted
3 Outside firms hired
8 Bills named

Spend is reported income plus in-house expenses across 20 filings. 3 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as UNITED STATES PHARMACOPEIAL CONVENTION.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 8
  • S. 1784
    MAPS Act
    7 filings
  • H.R. 4191
    MAPS Act
    6 filings
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    4 filings
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
    4 filings
  • S. 2587
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
    4 filings
  • H.R. 4779
    National Security, Department of State, and Related Programs Appropriations Act, 2026
    3 filings
  • S. 3788
    CLEAR LABELS Act
    3 filings
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
    2 filings
 Reported by year 2 years
  • 2026 $550,000 6 filings
  • 2025 $640,000 14 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • SENATE 15
  • HOUSE OF REPRESENTATIVES 14
  • Food & Drug Administration (FDA) 3
  • Centers For Medicare and Medicaid Services (CMS) 2
  • White House Office 1
 Recent filings 23 total
Q3 report
THE UNITED STATES PHARMACOPEIAL CONVENTION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $120,000 expenses · posted Oct 20, 2026
View →
Q3 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q1 amendment
THE UNITED STATES PHARMACOPEIAL CONVENTION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $130,000 expenses · posted Jul 20, 2026
View →
Q2 report
THE UNITED STATES PHARMACOPEIAL CONVENTION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $120,000 expenses · posted Jul 20, 2026
View →
Q2 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 13, 2026
View →
Q1 report
THE UNITED STATES PHARMACOPEIAL CONVENTION Amended
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $110,000 expenses · posted Apr 20, 2026
View →
Q1 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 15, 2026
View →
Q4 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View →
Q4 report
THE UNITED STATES PHARMACOPEIAL CONVENTION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $100,000 expenses · posted Jan 20, 2026
View →
Q3 amendment
CORNERSTONE GOVERNMENT AFFAIRS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · Senate · $20,000 income · posted Jan 15, 2026
View →
Q3 report
THE UNITED STATES PHARMACOPEIAL CONVENTION
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 expenses · posted Oct 20, 2025
View →
Q3 terminationNo activity
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2025 (July 1 - Sep 30) · $50,000 income · posted Oct 20, 2025
View →
Q3 report
CORNERSTONE GOVERNMENT AFFAIRS, INC. Amended
3rd Quarter 2025 (July 1 - Sep 30) · Senate · posted Oct 15, 2025
View →
Registration
CORNERSTONE GOVERNMENT AFFAIRS, INC.
3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 9, 2025
View →
Q3 terminationNo activity
HORIZON GOVERNMENT AFFAIRS
3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 3, 2025
View →
Q2 amendment
HORIZON GOVERNMENT AFFAIRS
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Sep 29, 2025
View →
Registration amendment
HORIZON GOVERNMENT AFFAIRS
2nd Quarter 2025 (Apr 1 - June 30) · posted Sep 29, 2025
View →
Q2 report
AKIN GUMP STRAUSS HAUER & FELD
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 21, 2025
View →
Q2 report
THE UNITED STATES PHARMACOPEIAL CONVENTION
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $110,000 expenses · posted Jul 21, 2025
View →
Q2 report
HORIZON GOVERNMENT AFFAIRS Amended
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 11, 2025
View →

Showing the 20 most recent of 23 filings. Search the explorer for "THE UNITED STATES PHARMACOPEIAL CONVENTION".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem